Researchers at Virginia Commonwealth University unveiled a genetic bullseye—a key gene that plays a pivotal role in initiating a genetic domino cascade, driving bone metastasis in prostate cancer.
A key gene that fuels the molecular cascade driving prostate cancer bone metastasis progression may open avenues for targeted therapies.